AMG 334 CGRP antibody for migraine: time to celebrate?

被引：8
|
作者：
Ramos, Marta L. [1 ,2 ]
Pascual, Julio [3 ,4 ]
机构：
[1] Hosp Occidente Kennedy, Dept Neurol, Bogota, Colombia
[2] Univ La Sabana, Bogota, Colombia
[3] Univ Hosp Marques Valdecilla, Santander 39008, Spain
[4] IDIVAL, Santander 39008, Spain
来源：
LANCET NEUROLOGY | 2016年 / 15卷 / 04期
关键词：
GENE-RELATED PEPTIDE; DOUBLE-BLIND; PREVENTIVE TREATMENT; EPISODIC MIGRAINE; PHASE; 2B; EFFICACY; SAFETY; TOLERABILITY; CIRCULATION; MULTICENTER;
D O I：
10.1016/S1474-4422(16)00040-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：347 / 349
页数：4
相关论文
共 50 条
  • [41] CGRP: New Focus in Migraine
    Karli, Necdet
    Bicakci, Sebnem
    Bozkurt, Manal Mehtar
    TURKISH JOURNAL OF NEUROLOGY, 2022, 28 (01) : 1 - 5
  • [42] CGRP and the Trigeminal System in Migraine
    Iyengar, Smriti
    Johnson, Kirk W.
    Ossipov, Michael H.
    Aurora, Sheena K.
    HEADACHE, 2019, 59 (05): : 659 - 681
  • [43] CGRP - The Next Frontier for Migraine
    Hershey, Andrew D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (22): : 2190 - 2191
  • [44] Discovery of CGRP in relation to migraine
    Edvinsson, Lars
    Goadsby, Peter J.
    CEPHALALGIA, 2019, 39 (03) : 331 - 332
  • [45] Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
    Damiana Scuteri
    Maria Tiziana Corasaniti
    Paolo Tonin
    Pierluigi Nicotera
    Giacinto Bagetta
    The Journal of Headache and Pain, 2021, 22
  • [46] Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
    Scuteri, Damiana
    Corasaniti, Maria Tiziana
    Tonin, Paolo
    Nicotera, Pierluigi
    Bagetta, Giacinto
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01):
  • [47] Time to Celebrate
    Palensky, Peter
    IEEE INDUSTRIAL ELECTRONICS MAGAZINE, 2021, 15 (01) : 3 - 3
  • [48] Pharmacologic Characterization of AMG 334, a Potent and Selective Human Monoclonal Antibody against the Calcitonin Gene-Related Peptide Receptor
    Shi, Licheng
    Lehto, Sonya G.
    Zhu, Dawn X. D.
    Sun, Hong
    Zhang, Jianhua
    Smith, Brian P.
    Immke, David C.
    Wild, Kenneth D.
    Xu, Cen
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 356 (01): : 223 - 231
  • [49] Erenumab (AMG334) An Antagonist to Canonical CGRP-Receptor Does Not Impair vasodilatory or Contractile Responses to Other Agents In Human Isolated Cerebral Arteries
    Ohlsson, Lena
    Kronvall, Erik
    Xu, Cen
    Snellman, Josefin
    Edvinsson, Lars
    NEUROLOGY, 2019, 92 (15)
  • [50] A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of AMG 334 for the Prevention of Episodic Migraine
    Sun, H.
    Silberstein, S.
    Dodick, D. W.
    Reuter, U.
    Ashina, M.
    Saper, J. R.
    Cady, R.
    Chon, Y.
    Dietrich, J.
    Lenz, R.
    HEADACHE, 2015, 55 : 132 - 132
12345